Loading...
•
Sep 30, 2020
Health Catalyst Q3 2020 Earnings Report
Health Catalyst reported strong performance in Q3 2020, exceeding revenue and Adjusted EBITDA guidance.
Key Takeaways
Health Catalyst reported a 20% increase in total revenue to $47.2 million and an adjusted EBITDA of negative $6.4 million for the third quarter of 2020. The company exceeded the midpoint of its quarterly guidance for both revenue and Adjusted EBITDA.
Total revenue increased by 20% year-over-year to $47.191 million.
Technology revenue increased by 32% year-over-year to $27.964 million.
Professional services revenue increased by 5% year-over-year to $19.227 million.
Adjusted EBITDA improved by 24% year-over-year to negative $6.434 million.
Health Catalyst
Health Catalyst
Health Catalyst Revenue by Segment
Revenue by Segment
Technology Revenue
CapyFin.comProfessional Services Revenue
CapyFin.com Forward Guidance
Health Catalyst expects total revenue between $50.5 million and $53.5 million and Adjusted EBITDA between $(7.3) million and $(5.3) million for the fourth quarter of 2020. For the full year 2020, the company expects total revenue between $186.1 million and $189.1 million and Adjusted EBITDA between $(23.9) million and $(21.9) million.
Positive Outlook
- Total revenue is expected to be between $50.5 million and $53.5 million for Q4 2020.
- Adjusted EBITDA is expected to be between $(7.3) million and $(5.3) million for Q4 2020.
- Total revenue is expected to be between $186.1 million and $189.1 million for the full year 2020.
- Adjusted EBITDA is expected to be between $(23.9) million and $(21.9) million for the full year 2020.
Revenue & Expenses
Visualization of income flow from segment revenue to net income